Suppr超能文献

心力衰竭患者心脏康复的预后影响(来自一项多中心前瞻性队列研究)。

Prognostic Effects of Cardiac Rehabilitation in Patients With Heart Failure (from a Multicenter Prospective Cohort Study).

机构信息

Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Cardiac Rehabilitation, Toyohashi Heart Center, Toyohashi, Japan.

出版信息

Am J Cardiol. 2022 Feb 1;164:79-85. doi: 10.1016/j.amjcard.2021.10.038. Epub 2021 Nov 27.

Abstract

The prognostic effects of cardiac rehabilitation (CR) are inconsistent in recent reports on heart failure (HF). Generally, participants in previous trials were relatively young and had HF with reduced ejection fraction. Herein, we examined the effects of CR on HF prognosis using a nationwide cohort study. This multicenter prospective cohort study included hospitalized patients with acute HF or worsening chronic HF. Patients who underwent CR once or more times weekly for 6 months after discharge were included in the CR group. The main study end point was a composite of all-cause mortality and HF rehospitalization during a 2-year follow-up period. We performed propensity score matching to compare the survival rates between the CR and non-CR groups. Of the 2,876 enrolled patients, 313 underwent CR for 6 months. After propensity score matching using confounding factors, 626 patients (313 pairs) were included in the survival analysis (median age: 74 years). CR was associated with a reduced risk of composite outcomes (hazard ratio [HR] 0.66; 95% confidence interval [CI] 0.48 to 0.91; p = 0.011), all-cause mortality (HR 0.53; 95% CI 0.30 to 0.95; p = 0.032), and HF rehospitalization (HR 0.66; 95% CI 47 to 0.92; p = 0.012). Subgroup analysis showed similar CR effects in patients with HF with preserved ejection fraction (≥50%) and HF with reduced ejection fraction (<40%). In the landmark analysis, CR did not reduce the aforementioned end points beyond 6 months after discharge (log-rank test: composite outcomes, p = 0.943; all-cause mortality, p = 0.258; HF rehospitalization, p = 0.831). CR is a standard treatment for HF regardless of HF type; however, further challenges may affect the long-term prognostic effects of CR.

摘要

心脏康复(CR)的预后效果在最近关于心力衰竭(HF)的报告中并不一致。一般来说,以前试验的参与者相对年轻,且射血分数降低的 HF。在此,我们使用全国性队列研究来检查 CR 对 HF 预后的影响。这项多中心前瞻性队列研究纳入了因急性 HF 或慢性 HF 恶化而住院的患者。出院后每周接受 CR 治疗一次或多次且持续 6 个月的患者被纳入 CR 组。主要研究终点是在 2 年随访期间全因死亡率和 HF 再住院的复合终点。我们进行倾向评分匹配以比较 CR 组和非 CR 组的生存率。在 2876 名入组患者中,有 313 名患者接受了 6 个月的 CR。使用混杂因素进行倾向评分匹配后,共有 626 名患者(313 对)纳入生存分析(中位年龄:74 岁)。CR 与复合结局风险降低相关(风险比 [HR] 0.66;95%置信区间 [CI] 0.48 至 0.91;p=0.011)、全因死亡率(HR 0.53;95%CI 0.30 至 0.95;p=0.032)和 HF 再住院率(HR 0.66;95%CI 47 至 0.92;p=0.012)。亚组分析显示,在射血分数保留(≥50%)和射血分数降低(<40%)HF 患者中,CR 具有相似的效果。在 landmark 分析中,CR 在出院后 6 个月后并未降低上述终点(对数秩检验:复合结局,p=0.943;全因死亡率,p=0.258;HF 再住院率,p=0.831)。CR 是 HF 的标准治疗方法,无论 HF 类型如何;然而,进一步的挑战可能会影响 CR 的长期预后效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验